| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/02/2008 | CN101209348A Elastic nano vesicle carrier and preparation and application thereof |
| 07/02/2008 | CN101209337A Medicinal liquor for treating rheumatism and rheumatoid and preparation thereof |
| 07/02/2008 | CN101209327A Method for preparing medicine for treating sprain and dampen |
| 07/02/2008 | CN101209326A Dampness eliminating medicinal liquor |
| 07/02/2008 | CN101209324A í«Penqiangjiní» capsule |
| 07/02/2008 | CN101209315A Chinese medicinal injection with antimicrobial and anti-inflammation, milk-smoothing and mass-dissipating efficacy |
| 07/02/2008 | CN101209309A Rheumatism treating medicine and preparation thereof |
| 07/02/2008 | CN101209300A Crab apple dispersible tablet and preparation |
| 07/02/2008 | CN101209291A Chinese medicine injection for animals with heat-clearing, detoxication wind-heat-removing efficacy |
| 07/02/2008 | CN101209288A Corydalis decumbentis orally disintegrating tablets |
| 07/02/2008 | CN101209276A China elder medicinal liqueur for expelling wind dissipating blood stasis and activating collateral flow |
| 07/02/2008 | CN101209274A Saussurea involucrata extract and saussurea involucrata catablasm and producing method thereof |
| 07/02/2008 | CN101209255A Forsythiaside injection preparations and preparation thereof |
| 07/02/2008 | CN100398544C Aqueous triptolide alcohol derivative with high immunesuppressive activity and its application |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 07/02/2008 | CN100398145C Medicine composition for treating chronic osteomyelitis and its preparation |
| 07/02/2008 | CN100398127C Wind dispelling spray and its preparation process |
| 07/02/2008 | CN100398107C Use of IkappaB-kinase inhibitors in preparing medicament for pain therapy |
| 07/01/2008 | US7393932 Endothelial cell expression patterns |
| 07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
| 07/01/2008 | US7393872 Sodium channel blocker compositions and the use thereof |
| 07/01/2008 | US7393869 3-[5-(4-methylbenzylidene)-4-oxo-2-thioxothiazolidin-3-yl]-N-(4-sulfamoylphenyl)-propionamide; compounds are protein tyrosine phosphatse inhibitors; antiinflmmatory, anticarcinogenic agents |
| 07/01/2008 | US7393858 Tetrahydropyran compounds as tachykinin antagonists |
| 07/01/2008 | US7393857 Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases |
| 07/01/2008 | US7393850 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 07/01/2008 | US7393846 phosphodiesterase type 4 inhibitors; N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide; antiinflammatory agent, antiallergen; asthma or chronic obstructive pulmonary disease |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 06/26/2008 | WO2008076949A2 Quinazoline derivatives and methods of treatment |
| 06/26/2008 | WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | WO2008075978A2 An extract |
| 06/26/2008 | WO2008075706A1 Therapeutic agent for interstitial pneumonia |
| 06/26/2008 | WO2008075353A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | WO2008075150A1 O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists |
| 06/26/2008 | WO2008075028A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | WO2008075025A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | WO2008075007A1 Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents |
| 06/26/2008 | WO2008074975A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | WO2008074752A2 Indolylmaleimide derivatives as kinase inhibitors |
| 06/26/2008 | WO2008074445A1 Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof |
| 06/26/2008 | WO2008036387A8 Method of treating endothelial dysfunction |
| 06/26/2008 | WO2008009639A3 New indications for direct thrombin inhibitors |
| 06/26/2008 | WO2007068736A3 New chemokine antagonists |
| 06/26/2008 | US20080153917 Sigma Receptor Ligands |
| 06/26/2008 | US20080153915 Pharmaceutical Preparation For the Oral Cavity |
| 06/26/2008 | US20080153914 Injectable Preparations Of Diclofenac And Its Pharmaceutically Acceptable Salts |
| 06/26/2008 | US20080153900 Administering an anti-microtubule agent such as campothecin, eleutherobin, sarcodictyins, epothilones, discodermolide, deuterium oxide, hexylene glycol, tubercidin or a taxane to treat diseases including psoriasis, arthritis, stenosis, graft rejection, vasculitis and inflammatory lung diseases |
| 06/26/2008 | US20080153885 Pharmaceutical compositions and method for treating inflammation in cattle and other animals |
| 06/26/2008 | US20080153879 Method of managing or treating pain |
| 06/26/2008 | US20080153872 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153859 5-{[6-Fluoro-2,5-dihydroxy-4,4,7-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-isoquinolin-1(2H)-one; anti-allergic, immunosuppressive and antiproliferative action |
| 06/26/2008 | US20080153855 Chemical Compounds |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153831 prevention and treatment of osteoporosis are provided herein. The compositions contain one or more isoflavones, such as genistein and derivatives thereof, in combination with one or more folates, such as a reduced folate and/or folic acid; and/or one or more polyunsaturated fatty acids (PUFAs), |
| 06/26/2008 | US20080153830 methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using alpha -adrenergic antagonists and beta -adrenergic agonists (particularly beta 2-adrenergic agonists) alone or in combination. |
| 06/26/2008 | US20080153818 Methods for preventing inflammation during surgery |
| 06/26/2008 | US20080153806 diagnostic test and method is provided comprising mixing blood or another biological fluid sample with a test compound and spotting the blood on filter paper for subsequent analysis of the effect of the test compound on the blood. The biological fluid can be a cerebrospinal |
| 06/26/2008 | US20080153790 Polymer coatings as carriers for the drug delivery of a derivative of a methoxyaminocarbonyloxy-rapamycin and another drug(s) such as an antiproliferative agent, anticoagulant, etc.; reduces restenosis in vasculature procedures; to a level of 0-25%; coronary/periferal stents; grafts ; balloons |
| 06/26/2008 | US20080153776 Administering to an eye an aqueous solution of alginate having a minimum of about 50% mannuronate residues based upon the total number of saccharide monomeric units; no active pharmaceutical agent |
| 06/26/2008 | US20080153756 Nucleic acids encoding them; for use in modulating alpha 4 integrin function; kits; antibodies against the peptides |
| 06/26/2008 | US20080153752 artificial polypeptides as inhibitor of hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, heparin, keratan sulfate, keratosulfate, chitin, chitosan 1, and chitosan 2; for treatment of inflammatory diseases, tumor, cancer, cancer metastasis, and autoimmune diseases |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080153107 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 06/26/2008 | US20080152737 Plant extracts; cosmetics; galactolipids |
| 06/26/2008 | US20080152734 Oil-soluble licorice extract; Glycyrrhiza extract; hexosaminidase, phospholipase inhibitors |
| 06/26/2008 | US20080152656 Using kallikren specific inhibitor as therapeutic tool in treating cardiocascular disorders; treating soft tissue and bone trauma; tissue repair |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152629 Progenitor cell culture for use in partial and/or full restoration of hematopoietic function in patients who have undergone ablative therapy |
| 06/26/2008 | DE20122843U1 Fentanyl Zusammensetzung zur nasalen Anwendung Fentanyl composition for nasal administration |
| 06/26/2008 | CA2695613A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | CA2673219A1 O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists |
| 06/26/2008 | CA2673214A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | CA2672976A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | CA2672792A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | CA2671668A1 Therapeutic composition for interstitial pheumonia |
| 06/26/2008 | CA2671525A1 Indolylmaleimide derivatives |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1935413A1 Iontophoresis preparation for treatment of breast cancer and/or mastitis |
| 06/25/2008 | EP1934236A1 Heterobifunctional pan-selectin inhibitors |
| 06/25/2008 | EP1934223A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 06/25/2008 | EP1934203A2 Alpha2c adrenoreceptor agonists |
| 06/25/2008 | EP1934176A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 06/25/2008 | EP1934173A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 06/25/2008 | EP1933861A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 06/25/2008 | EP1933853A1 Tissue disruption treatment and composition for use thereof |
| 06/25/2008 | EP1933851A1 Vitamin b-12 compositions |
| 06/25/2008 | EP1933847A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| 06/25/2008 | EP1933835A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides |
| 06/25/2008 | EP1933834A1 Benzoxazoles useful in the treatment of inflammation |
| 06/25/2008 | EP1933826A1 Method of production of fine-crystalline mixture containing non-steroid anti-inflammatory drug, fine-crystalline mixture obtainable by this method and solid pharmaceutical composition containing this mixture |
| 06/25/2008 | EP1933622A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 06/25/2008 | EP1675854B1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 06/25/2008 | EP1670796B1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/25/2008 | EP1560834B1 New tricyclic derivatives as ltd4 antagonists |
| 06/25/2008 | EP1463755B1 Recombinant polypeptides |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 06/25/2008 | EP1328271B1 Treatment of neurological and neuropsychological disorders |